Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Simulations Plus, Inc.

Get SEC filing alerts via email and in your feed for Simulations Plus, Inc.

SLP

Simulations Plus, Inc.

About Simulations Plus, Inc.

Simulations Plus, Inc. provides software and consulting services for drug discovery, development, and regulatory approval. Its core offerings include modeling and simulation tools like GastroPlus and ADMET Predictor, supporting pharmaceutical, biotech, and academic clients worldwide. The company enhances R&D efficiency, reduces costs, and accelerates time-to-market through innovative science-based solutions across the drug development continuum. It operates with a focus on scientific expertise, proprietary technology, and global customer relationships.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Simulations Plus, Inc.

1
1
Simulations Plus, Inc. Simulations Plus Reports 8% Revenue Growth to $24.3 Million in Q2 Fiscal 2026

Via official filing (AI summary) | about 2 months ago | 0 comments

2
1
Simulations Plus, Inc. Simulations Plus Reports 3% Revenue Decline, Net Income Increases to $0.7 Million

Via official filing (AI summary) | 5 months ago | 0 comments

3
1
Simulations Plus, Inc. Simulations Plus Reports 13% Revenue Increase to $79.2 Million Amid Significant Impairment Charge

Via official filing (AI summary) | 6 months ago | 0 comments

4
1
Simulations Plus, Inc. Simulations Plus Reports $67.3 Million Net Loss in Q3 2025 Amid Revenue Growth

Via official filing (AI summary) | 11 months ago | 0 comments

5
1
Simulations Plus, Inc. Simulations Plus Reports 23% Revenue Growth in Q2 Fiscal Year 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Simulations Plus, Inc. Simulations Plus Reports 30% Revenue Growth in Q1 FY 2024, Net Income Declines

Via official filing (AI summary) | over 1 year ago | 0 comments